Abdelrahman Hamdi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Molecular Docking

Binding Protein

Metastatic Colorectal Cancer

Top Venues

Molecules (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Samar S Tawfik, Abdelrahman Hamdi, Ahmed R Ali, Abdullah A Elgazar, Hamed W El-Shafey, Adel S El-Azab, Ahmed H Bakheit, Mohamed M Hefnawy, Hazem A Ghabour, Alaa A-M Abdel-Aziz
S -Alkylated quinazolin-4(3 H )-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study. RSC advances 14 (36) (2024)
Shimaa A Abass, Abdullah A Elgazar, Sanad S El-Kholy, Amal I El-Refaiy, Reem A Nawaya, Mashooq Ahmad Bhat, Foad A Farrag, Abdelrahman Hamdi, Marwa Balaha, Mohammed Abu El-Magd
Unraveling the Nephroprotective Potential of Papaverine against Cisplatin Toxicity through Mitigating Oxidative Stress and Inflammation: Insights from In Silico, In Vitro, and In Vivo Investigations. Molecules (Basel, Switzerland) 29 (9) (2024)
Wafaa A Ewes, Samar S Tawfik, Aya M Almatary, Mashooq Ahmad Bhat, Hamed W El-Shafey, Ahmed A B Mohamed, Abdullah Haikal, Mohammed Abu El-Magd, Abdullah A Elgazar, Marwa Balaha, Abdelrahman Hamdi
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules (Basel, Switzerland) 29 (13) (2024)
Samar S Tawfik, Abdelrahman Hamdi, Ahmed R Ali, Abdullah A Elgazar, Hamed W El-Shafey, Adel S El-Azab, Ahmed H Bakheit, Mohamed M Hefnawy, Hazem A Ghabour, Alaa A-M Abdel-Aziz
S -Alkylated quinazolin-4(3 H )-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study. RSC advances 14 (36) (2024)
Shimaa A Abass, Abdullah A Elgazar, Sanad S El-Kholy, Amal I El-Refaiy, Reem A Nawaya, Mashooq Ahmad Bhat, Foad A Farrag, Abdelrahman Hamdi, Marwa Balaha, Mohammed Abu El-Magd
Unraveling the Nephroprotective Potential of Papaverine against Cisplatin Toxicity through Mitigating Oxidative Stress and Inflammation: Insights from In Silico, In Vitro, and In Vivo Investigations. Molecules (Basel, Switzerland) 29 (9) (2024)
Wafaa A Ewes, Samar S Tawfik, Aya M Almatary, Mashooq Ahmad Bhat, Hamed W El-Shafey, Ahmed A B Mohamed, Abdullah Haikal, Mohammed Abu El-Magd, Abdullah A Elgazar, Marwa Balaha, Abdelrahman Hamdi
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules (Basel, Switzerland) 29 (13) (2024)
Wafaa A Ewes, Samar S Tawfik, Aya M Almatary, Mashooq Ahmad Bhat, Hamed W El-Shafey, Ahmed A B Mohamed, Abdullah Haikal, Mohammed Abu El-Magd, Abdullah A Elgazar, Marwa Balaha, Abdelrahman Hamdi
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules (Basel, Switzerland) 29 (13) (2024)
Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A Ewes, Mashooq Ahmad Bhat, Noha I Ziedan, Hamed W El-Shafey, Ahmed A B Mohamed, Mohamed R Elnagar, Abdullah Haikal, Dina I A Othman, Abdullah A Elgazar, Ahmed H A Abusabaa, Kamal S Abdelrahman, Osama M Soltan, Mostafa M Elbadawi
Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)